Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

EF Hutton Maintains Buy on Apollomics, Lowers Price Target to $6.5

Author: Benzinga Newsdesk | April 01, 2024 08:38am
EF Hutton analyst Michael King maintains Apollomics (NASDAQ:APLM) with a Buy and lowers the price target from $11 to $6.5.

Posted In: APLM

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist